Surya Singh, MD, Joins D2Hawkeye as Senior Vice President, Client Solutions and Clinical Operations

Printer-friendly versionPDF version

Dr. Singh Brings Clinical Expertise to D2Consulting Unit and Clinical Team

Waltham, MA

, January 24, 2007 -D2Hawkeye, a leader in healthcare data analytics, announced the appointment of Surya Singh, M.D. as Senior Vice President, Client Solutions and Clinical Operations. In this role, Dr. Singh will manage and drive clinical input into product development and research, provide clinical support for key client relationships, and help shape the new D2Consulting Unit. 

Dr. Singh's background combines medicine and consulting. He received his medical degree from the Johns Hopkins Medical School and completed his residency in internal medicine at the Brigham and Women's Hospital and Harvard Medical School. After completing his residency, Dr. Singh stayed on at the Brigham and Women's and Faulkner Hospitals as a hospitalist, and also became an Instructor of Medicine at Harvard Medical School. He currently continues to treat patients and teach medical students and residents part-time in these same roles.

Following his training and a brief period of full-time clinical practice, Dr. Singh joined McKinsey & Company, a leading management consulting firm. At McKinsey, he rapidly became an Engagement Manager and focused his efforts on counseling the leadership of healthcare companies, including providers, health insurers, pharmaceuticals, medical device companies, and healthcare IT companies. 

Dr. Singh's work at McKinsey included leading the effort to create a comprehensive quality strategy for a top ten U.S. academic medical center, managing the creation of a growth strategy for a Fortune 500 medical device company, helping to author and implement a set of growth initiatives for a major hospital chain, and co-authoring/ modeling a strategic vision for EHR adoption and use among various healthcare stakeholders.

"Dr. Singh's arrival at D2 adds expertise to the company's doctor-driven team," said Chris Kryder, M.D., founder, chairman and CEO of D2Hawkeye. "His experience as both a practicing clinician and advisor to a broad range of healthcare companies provides a unique clinical perspective that will benefit our clients and our company as a whole." 

"I am excited by D2's approach to improving medical management and creating tools to help manage clinical risk. I strongly believe medical data, and the ability to effectively mine it, analyze it, and operationalize the findings is fundamentally changing the way we think about healthcare." commented Dr. Singh. "D2 is at the forefront of this market disruption, and I'm looking forward to helping clients extract the information they need to deliver high quality care to those who need it most."

About D2Hawkeye, Inc.®

D2Hawkeye is the leading provider of medical data reporting and analytics solutions. The company rapidly integrates all of a population’s eligibility, medical claims, pharmacy claims, health risk assessment and case management data, and then applies a wide range of medical rules in order to predict individual and aggregate risk in that population. Through the use of intensive data mining techniques, D2Hawkeye automates the analytical process, enabling its clients to make medical management and financial decisions in a more effective and timely manner. Based in Waltham, MA, D2Haweye is privately held. For more information, please visithttp://www.d2hawkeye.com.

For Additional Information Contact:

Sara Fraim, 781-693-3763             

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

">

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

http://www.d2hawkeye.com/content/view/165/432/